All data are based on the daily closing price as of May 12, 2026
e
Euglena
2931.TSE
2.54 USD
-0.03
-1.17%
Overview
Last close
2.54 usd
Market cap
353.45M usd
52 week high
3.58 usd
52 week low
2.28 usd
Target price
2.54 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.1169
Price/Book Value
1.8037
Enterprise Value
395.69M usd
EV/Revenue
1.238
EV/EBITDA
10.9379
Key financials
Revenue TTM
319.63M usd
Gross Profit TTM
222.31M usd
EBITDA TTM
41.06M usd
Earnings per Share
-0.04 usd
Dividend
0.01 usd
Total assets
461.86M usd
Net debt
41.61M usd
About
Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and social businesses; and invests in biotechnology related businesses. Further, the company provides genome analysis services. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.